glp 1 vs glp 1/gip The activity of GLP-1 and GIP for Type 2 Diabetes and Obesity GLP-1/GIP Receptor Agonists and Diabetic
Description
How It Works Fast and simple from start to finish
(21) They found that semaglutide was associated with increased CTX-1 levels (p = .021) and reduced BMD at weight-bearing sites, including the lumbar spine (p = .007), total hip (p = .001), and tibia (p = .003)
doi: 10.7570/jomes22001
It fundamentally changes what this class of drugs can achieve
Conventional and genetic evidence on the association between adiposity and CKD
